Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | Director | December 31, 2025 | January 05, 2026 |
| Fortune Brands Innovations, Inc.FBIN · Entity 3896 | Director | May 05, 2026 | May 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,167.3933 |
Reported balance
After 2025-02-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-02-14 · Grant · Acquired 74.9914 · Balance 9,167.3933 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,250.3869 |
Reported balance
After 2025-05-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-09 · Grant · Acquired 82.9936 · Balance 9,250.3869 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,347.4299 |
Reported balance
After 2025-08-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-08-29 · Grant · Acquired 97.043 · Balance 9,347.4299 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,456.4891 |
Reported balance
After 2025-11-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-11-06 · Grant · Acquired 109.0592 · Balance 9,456.4891 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,094.3468 |
Reported balance
After 2025-12-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-12-31 · Grant · Acquired 1,637.8577 · Balance 11,094.3468 F1: 1-for-1 F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
Fortune Brands Innovations, Inc.
Report date May 05, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, Par Value $0.01SEC Table I · non-derivative | Direct | 29,509 |
Reported balance
After 2026-05-05 transaction · row 1
1 source rowRow 1 · 2026-05-05 · Grant · Acquired 4,191 · Balance 29,509 F1: Reflects a grant of stock under the Issuer's Long-Term Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of stock under the Issuer's Long-Term Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2018 Filed Jan 3, 2019 21:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 8.6999 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000388 · doc4.xml · derivative · entry 3 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,345.6695 Underlying: Common Stock · 8.6999 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 11, 2018 Filed Jan 3, 2019 21:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 10.5637 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000388 · doc4.xml · derivative · entry 2 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,336.9696 Underlying: Common Stock · 10.5637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| April 30, 2018 Filed May 1, 2018 20:04 UTC | Fortune Brands Innovations, Inc. FBHS · Entity 3896 | GrantCommon Stock, Par Value $0.01 | 2,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-027057 · doc4.xml · nonDerivative · entry 1 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,085 F1 · kind: Reflects a grant of stock under the Fortune Brands Home & Security, Inc. 2013 Long-Term Incentive Plan. Read SEC document |
| February 09, 2018 Filed Jan 3, 2019 21:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 8.5944 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-000388 · doc4.xml · derivative · entry 1 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,326.4059 Underlying: Common Stock · 8.5944 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 23:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,002.0689 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000441 · doc4.xml · derivative · entry 5 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,317.8115 Underlying: Common Stock · 1,002.0689 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 13, 2017 Filed Jan 3, 2018 23:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1.9513 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000441 · doc4.xml · derivative · entry 4 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315.7425 Underlying: Common Stock · 1.9513 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 04, 2017 Filed Jan 3, 2018 23:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1.9477 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000441 · doc4.xml · derivative · entry 3 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313.7912 Underlying: Common Stock · 1.9477 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 05, 2017 Filed Jan 3, 2018 23:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1.8661 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000441 · doc4.xml · derivative · entry 2 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311.8435 Underlying: Common Stock · 1.8661 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:15 UTC | Fortune Brands Innovations, Inc. FBHS · Entity 3896 | GrantCommon Stock, Par Value $0.01 | 2,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-029644 · doc4.xml · nonDerivative · entry 1 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,617 F1 · kind: Reflects a grant of stock under the Fortune Brands Home & Security, Inc. 2013 Long-Term Incentive Plan. Read SEC document |
| February 10, 2017 Filed Jan 3, 2018 23:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1.9399 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000441 · doc4.xml · derivative · entry 1 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309.9774 Underlying: Common Stock · 1.9399 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 308.0375 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000372 · doc4.xml · derivative · entry 1 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308.0375 Underlying: Common Stock · 308.0375 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 21:46 UTC | CLOROX CO /DE/ CLX · Entity 3474 | PurchaseCommon Stock | 2,500 | $113.75 | $284,364.00 |
DisclosureSEC source: 0001225208-16-042616 · doc4.xml · nonDerivative · entry 2 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 5,000 F2 · price: This transaction was executed in multiple trades at prices ranging from $113.71 to $113.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 21:46 UTC | CLOROX CO /DE/ CLX · Entity 3474 | PurchaseCommon Stock | 2,500 | $116.05 | $290,119.00 |
DisclosureSEC source: 0001225208-16-042616 · doc4.xml · nonDerivative · entry 1 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 2,500 F1 · price: This transaction was executed in multiple trades at prices ranging from $116.03 to $116.05. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.